Eastern Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.8K | Hold |
1,000
| – | – | ﹤0.01% | 702 |
|
|
2025
Q1 | $15.4K | Hold |
1,000
| – | – | ﹤0.01% | 733 |
|
|
2024
Q4 | $22K | Buy |
+1,000
| New | +$22K | ﹤0.01% | 680 |
|
|
2016
Q4 | – | Sell |
-37,985
| Closed | -$1.75M | – | 204 |
|
|
2016
Q3 | $1.75M | Sell |
37,985
-947
| -2% | -$43.6K | 0.14% | 102 |
|
|
2016
Q2 | $1.96M | Buy |
38,932
+1,609
| +4% | +$80.8K | 0.16% | 98 |
|
|
2016
Q1 | $2M | Buy |
37,323
+1,016
| +3% | +$54.4K | 0.16% | 97 |
|
|
2015
Q4 | $2.38M | Sell |
36,307
-628
| -2% | -$41.2K | 0.2% | 84 |
|
|
2015
Q3 | $2.09M | Buy |
+36,935
| New | +$2.09M | 0.18% | 89 |
|
|
2013
Q4 | – | Sell |
-7,882
| Closed | -$297K | – | 212 |
|
|
2013
Q3 | $297K | Sell |
7,882
-45
| -0.6% | -$1.7K | 0.03% | 177 |
|
|
2013
Q2 | $310K | Buy |
+7,927
| New | +$310K | 0.03% | 166 |
|